India, July 20 -- India has taken a major step in tackling dengue after the Central Drugs Standard Control Organisation (CDSCO) approved Takeda's QDENGA (TAK-003), the country's first approved dengue vaccine.

The approval comes as dengue cases continue to rise due to urbanisation, climate change, changing mosquito habitats and population growth.

A Major Boost in India's Fight Against Dengue QDENGA is a live-attenuated tetravalent vaccine that protects against all four dengue virus serotypes-DENV-1, DENV-2, DENV-3 and DENV-4. It does not require a prior blood test to determine whether a person has previously had dengue. The vaccine has already been approved in more than 40 countries, including the European Union, the United Kingdom, Bra...